MSFT 435.0 0.7061% AAPL 230.65 -1.2924% NVDA 139.965 -0.9097% GOOGL 176.965 4.2934% GOOG 178.65 4.3882% AMZN 193.73 1.5197% META 594.31 0.1736% AVGO 177.28 -1.0935% TSLA 262.2401 1.0481% TSM 195.14 -0.914% LLY 831.501 -7.977% V 291.3 3.3418% JPM 224.685 0.8008% UNH 564.77 0.4696% NVO 113.15 1.0448% WMT 81.58 -0.1469% LVMUY 134.2 -1.4033% XOM 117.0342 -0.2096% LVMHF 670.0 -1.3008% MA 513.51 1.4281%
Last update at 2024-10-30T18:56:00Z
3 Heavily Shorted Stocks That Are Down More Than 75% Since 2021. Can They Turn Things Around?
Fri 18 Oct 24, 11:10 AMMedical Properties (MPW) Laps the Stock Market: Here's Why
Wed 16 Oct 24, 09:50 PMAfter a Thorough Investigation, This High-Yield Dividend Stock Earns a Clean Bill of Health
Wed 16 Oct 24, 10:39 AMBuying Medical Properties Trust Taught Me a Costly Lesson
Sat 12 Oct 24, 11:38 AMWhy Medical Properties Trust Stock Got Socked Today
Thu 10 Oct 24, 10:11 PMA Company Taking Over Steward Hospitals Has Struggled With Its Own Portfolio
Mon 07 Oct 24, 07:15 PMMedical Properties (MPW) Stock Slides as Market Rises: Facts to Know Before You Trade
Thu 26 Sep 24, 10:00 PMMPW Stock Surges 33.9% in a Month: Should You Buy Now or Wait?
Thu 26 Sep 24, 06:06 PMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 959.72M | 730.89M | 463.33M | 373.78M | 1019.40M |
Minority interest | -1.22200M | -0.91900M | 0.82M | 1.72M | 1.79M |
Net income | 902.60M | 656.02M | 431.45M | 374.68M | 1016.68M |
Selling general administrative | 160.49M | 145.64M | 131.66M | 96.41M | 80.09M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 1497.15M | 1505.57M | 1224.35M | 830.21M | 775.28M |
Reconciled depreciation | 332.98M | 321.25M | 275.95M | 156.57M | 141.49M |
Ebit | 735.30M | 986.21M | 850.28M | 560.95M | 1240.89M |
Ebitda | 1068.28M | 1307.46M | 1114.52M | 713.26M | 1382.38M |
Depreciation and amortization | 332.98M | 321.25M | 264.25M | 152.31M | 141.49M |
Non operating income net other | 315.07M | 59.60M | -36.38400M | 30.13M | 681.48M |
Operating income | 735.30M | 986.21M | 850.28M | 560.95M | 562.12M |
Other operating expenses | 539.17M | 505.99M | 420.80M | 272.72M | 222.41M |
Interest expense | -355.03600M | 256.24M | 387.77M | 237.83M | 223.27M |
Tax provision | 55.90M | 73.95M | 31.06M | -2.62100M | 0.93M |
Interest income | 327.69M | 366.56M | 336.49M | 227.88M | 223.27M |
Net interest income | -368.48800M | -395.04300M | -356.90800M | -243.93600M | -223.27400M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 55.90M | 73.95M | 31.06M | -2.62100M | 0.93M |
Total revenue | 1542.85M | 1544.67M | 1249.24M | 854.20M | 784.52M |
Total operating expenses | 493.47M | 466.89M | 395.91M | 248.72M | 213.17M |
Cost of revenue | 45.70M | 39.10M | 24.89M | 23.99M | 9.24M |
Total other income expense net | 224.42M | -255.32500M | -386.95100M | -187.17200M | 457.29M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 903.82M | 656.94M | 432.27M | 376.40M | 1018.48M |
Net income applicable to common shares | 901.00M | 656.02M | 431.45M | 374.68M | 1016.68M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Total assets | 19658.00M | 20519.80M | 16829.01M | 14467.33M | 8843.64M |
Intangible assets | 1394.47M | 1417.81M | 1299.08M | 622.06M | 403.14M |
Earning assets | - | - | - | - | - |
Other current assets | 304.52M | -2053.32700M | 87.95M | 90.34M | 61.76M |
Total liab | 11063.59M | 12074.13M | 9485.16M | 7439.18M | 4282.70M |
Total stockholder equity | 8592.84M | 8440.19M | 7338.53M | 7028.05M | 4547.11M |
Deferred long term liab | 12.04M | 5.49M | 0.19M | 2.49M | 4.79M |
Other current liab | -929.58400M | -991.81400M | 273.34M | 291.49M | 204.32M |
Common stock | 0.60M | 0.60M | 0.54M | 0.52M | 0.37M |
Capital stock | 0.60M | 0.60M | 0.54M | 0.52M | 0.37M |
Retained earnings | 116.28M | -87.69100M | -71.41100M | 83.01M | 162.77M |
Other liab | 70.33M | 183.57M | 180.95M | 45.72M | 40.99M |
Good will | 12467.94M | 12644.91M | - | - | - |
Other assets | 632.58M | 3888.30M | 14980.05M | 1484.28M | 1333.53M |
Cash | 235.67M | 459.23M | 549.88M | 1462.29M | 820.87M |
Cash and equivalents | 235.67M | 459.23M | 549.88M | 1462.29M | 820.87M |
Total current liabilities | 649.05M | 633.36M | 474.93M | 307.59M | 217.79M |
Current deferred revenue | 27.73M | 25.56M | 36.18M | 16.10M | 13.47M |
Net debt | 11108.46M | 10981.55M | 8460.35M | 5669.30M | 3244.05M |
Short term debt | 929.58M | 1599.61M | 165.41M | 107.91M | 28.06M |
Short long term debt | 929.58M | 1599.61M | 165.41M | - | 28.06M |
Short long term debt total | 11344.13M | 11440.77M | 9010.23M | 7131.59M | 4064.91M |
Other stockholder equity | 8535.14M | 8564.01M | 7460.73M | 7007.42M | 4441.97M |
Property plant equipment | 17667.30M | 13069.62M | 9946.32M | 6910.66M | 4400.34M |
Total current assets | 1417.71M | 2572.63M | 1944.92M | 2372.71M | 1067.57M |
Long term investments | 2942.78M | 1181.03M | 1371.70M | 2202.01M | 1897.38M |
Net tangible assets | 7198.37M | 8440.19M | 6039.45M | 6405.99M | 4143.97M |
Short term investments | 1691.32M | 2053.33M | - | - | - |
Net receivables | 1182.04M | 2113.40M | 1395.04M | 910.42M | 246.70M |
Long term debt | 10268.41M | 11282.77M | 8865.46M | 7023.68M | 4037.39M |
Inventory | -304.51600M | 2053.33M | - | - | -61.75700M |
Accounts payable | 621.32M | 607.79M | 438.75M | -107.91100M | -28.05900M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | 1.57M | 5.48M | 5.33M | 0.11M | 13.83M |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -59.18400M | -36.72700M | -51.32400M | -62.90500M | -58.20200M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | 0.60M | 0.60M | 0.54M | 0.52M | 0.37M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | 116.28M | -87.69100M | -71.41100M | 83.01M | 162.77M |
Treasury stock | - | -0.77700M | -0.77700M | -0.77700M | -0.77700M |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | -12427.31300M | 15348.33M | 12461.39M | 10545.58M | 6852.88M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 18240.29M | 17947.17M | 14884.09M | 12094.62M | 7776.07M |
Capital lease obligations | 146.13M | 158.00M | 144.77M | 107.91M | 27.52M |
Long term debt total | 10268.41M | 11282.77M | 8865.46M | 7023.68M | 4037.39M |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Investments | -139.92500M | 1602.32M | 1312.76M | -53.16800M | 535.47M |
Change to liabilities | 33.58M | 54.06M | -18.42400M | 39.63M | -5.59600M |
Total cashflows from investing activities | 396.06M | -3858.41300M | -2946.77300M | -4883.95700M | 564.18M |
Net borrowings | -537.49400M | 2576.53M | 1578.58M | 2952.50M | -51.98300M |
Total cash from financing activities | -1342.52300M | 2947.61M | 1401.07M | 5041.88M | -345.87000M |
Change to operating activities | -4.02900M | -4.37500M | 18.26M | -4.99200M | -18.05100M |
Net income | 903.82M | 656.94M | 432.27M | 376.40M | 1018.48M |
Change in cash | -220.34400M | -94.48700M | -911.62200M | 645.57M | 650.18M |
Begin period cash flow | 461.88M | 556.37M | 1467.99M | 822.42M | 172.25M |
End period cash flow | 241.54M | 461.88M | 556.37M | 1467.99M | 822.42M |
Total cash from operating activities | 739.01M | 811.66M | 617.64M | 494.12M | 449.09M |
Issuance of capital stock | 0.00000M | 1051.23M | 411.10M | 2533.21M | 94.24M |
Depreciation | 345.58M | 333.78M | 275.95M | 156.57M | 141.49M |
Other cashflows from investing activities | 1868.94M | -110.49600M | -10.35300M | -265.19500M | 1459.70M |
Dividends paid | -698.53500M | -643.47300M | -567.96900M | -411.69700M | 363.91M |
Change to inventory | - | - | - | -39.63000M | 5.60M |
Change to account receivables | -116.42000M | -23.86700M | -2.43800M | 12.91M | 46.50M |
Sale purchase of stock | -47.86200M | 3967.52M | 2378.58M | 3048.42M | 759.74M |
Other cashflows from financing activities | 273.48M | -36.67400M | -20.64100M | -62.31700M | -24.22000M |
Change to netincome | -481.22600M | 11.55M | 86.42M | 16.30M | -731.45700M |
Capital expenditures | 1332.96M | 65.55M | 4249.18M | 27.97M | 1459.70M |
Change receivables | - | - | - | - | - |
Cash flows other operating | -79.78100M | -261.53100M | -171.68600M | -103.66600M | 18.81M |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | -207.45700M | -99.14900M | -928.06300M | 652.04M | 667.40M |
Change in working capital | 29.59M | 13.12M | 17.22M | 53.12M | 23.00M |
Stock based compensation | 49.42M | 52.11M | 47.15M | 32.19M | 16.50M |
Other non cash items | -600.09400M | -287.04000M | -176.80300M | -103.64300M | -78.99700M |
Free cash flow | 739.01M | 746.11M | 617.64M | 494.12M | 449.09M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
MPW Medical Properties Trust Inc |
0.09 1.82% | 4.75 | - | 6.67 | 2.04 | 0.35 | 9.37 | 23.21 |
WELL Welltower Inc |
1.02 0.74% | 138.36 | 170.68 | 72.46 | 7.75 | 2.13 | 9.77 | 27.67 |
VTR Ventas Inc |
0.70 1.06% | 66.73 | 2524.00 | 25.51 | 4.47 | 1.98 | 7.44 | 17.76 |
OHI Omega Healthcare Investors Inc |
0.76 1.81% | 42.64 | 31.33 | 10.13 | 9.06 | 2.05 | 14.35 | 15.26 |
HR Healthcare Realty Trust Incorporated |
-0.305 1.68% | 17.84 | - | 10.83 | 4.82 | 0.93 | 8.92 | 15.95 |
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023. Since the end of the third quarter, the Company has sold four facilities and now owns approximately 43,000 licensed beds in nine countries across three continents. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
1000 Urban Center Drive, Birmingham, AL, United States, 35242
Name | Title | Year Born |
---|---|---|
Mr. Edward K. Aldag Jr. | Founder, Chairman, Pres & CEO | 1964 |
Mr. Emmett E. McLean | Founder, Exec. VP, COO & Sec. | 1955 |
Mr. R. Steven Hamner CPA | Founder, Exec. VP, CFO & Director | 1957 |
Mr. James Kevin Hanna | Chief Accounting Officer, VP & Controller | 1973 |
Mr. Tim Berryman | Managing Director of Investor Relations | NA |
Mr. Andrew T. Babin C.F.A. | Sr. Managing Director of Corp. Communications | NA |
Ms. Rosa H. Hooper | VP and MD of Asset Management & Underwriting | NA |
Mr. Jamey Ramsey | Managing Director of Tax | NA |
Mr. R. Lucas Savage | VP & Head of Global Acquisitions | NA |
Mr. Charles R. Lambert | VP, Treasurer & MD of Capital Markets | 1971 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.